Posts

Showing posts from June, 2026

Sleep Deprivation Linked to Increased ERM Risk

Image
  A South Korean study published in Retina has identified weekday sleep deprivation (defined as averaging less than six hours of sleep per night) as a potential modifiable risk factor for developing an epiretinal membrane (ERM) . Key Findings Increased Risk: Analyzing data from 15,240 participants, researchers found that sleep deprivation is associated with a 1.25-fold increase in ERM prevalence. Vulnerable Groups: The association was particularly pronounced among individuals with diabetes (1.26-fold risk) and non–high-risk alcohol consumers (1.22-fold risk). Predictive Power: Insufficient sleep ranked as the fourth most influential predictor (5.3%) for ERM development, following age, cataract surgery, and dyslipidemia. Underlying Mechanisms & Study Limitations Researchers suggest that chronic short sleep may fuel ERM formation by inducing low-grade systemic inflammation and disrupting vascular homeostasis, which compromises the eye's ability to clear inflammatory med...

Omega-3 Fatty Acids and Glaucoma Risk

Image
A retrospective cohort study published in Translational Vision Science & Technology suggests that omega-3 fatty acid supplementation may significantly lower the risk of developing glaucoma in individuals with dry eye disease. Researchers analyzed data from 14,168 adult patients across a multinational database between 2013 and 2023. They compared a group prescribed omega-3 supplements against a matched control group over a five-year follow-up period. Key Findings Compared to the control group, patients who received omega-3 supplements experienced substantially lower risks across multiple conditions: Total Glaucoma: Risk reduced by 52% (HR: 0.48) Primary Open-Angle Glaucoma (POAG): Risk reduced by 55% (HR: 0.45) Normal-Tension Glaucoma (NTG): Risk reduced by 59% (HR: 0.41) Ocular Hypertension: Risk reduced by 43% (HR: 0.57) Primary Angle-Closure Glaucoma (PACG): Risk reduced by 55% (HR: 0.45) First-Line Glaucoma Medication Use: Risk reduced by 35% (HR: 0.65) Biological...

OCT-A Biomarker Predicts Early Glaucoma Progression

Image
A 4.9-year longitudinal study published in the American Journal of Ophthalmology suggests that microvasculature dropout (MvD) detected via OCT angiography (OCT-A) serves as a critical prognostic marker for patients with preperimetric glaucoma (optic nerve damage without initial visual field loss). Key Study Findings Faster Vascular Decline: Eyes with baseline MvD experienced a significantly faster reduction in circumpapillary capillary density compared to those without MvD ( -0.88% per year vs. -0.23% per year ). Higher Conversion Rates: Over an average follow-up of 6.8 years, 62.5% of eyes with baseline MvD progressed to perimetric glaucoma (measurable visual field loss), compared to just 26.2% of eyes without it—a 2.5-fold higher risk. Baseline Vulnerability: At the start of the study, the MvD group already exhibited lower capillary density (45.6% vs. 47.7%) and thinner retinal nerve fiber layers (RNFL) than the control group. Clinical Takeaways Because capillary density loss...